Summary:
- This article discusses the results of a Phase 2 clinical trial for a drug called Encaleret, which is being developed to treat a condition called post-surgical hypoparathyroidism.
- Hypoparathyroidism is a condition where the parathyroid glands do not produce enough parathyroid hormone, which is important for regulating calcium levels in the body.
- The study found that Encaleret was able to normalize blood and urine calcium levels in patients with post-surgical hypoparathyroidism, without the need for parathyroid hormone replacement therapy.